NPI: 1427063270 · BRONX, NY 10451 · Internal Medicine Physician · NPI assigned 07/30/2006
Authorized official KARLIN, MARJI controls 19+ related entities in our dataset. Read more
| Authorized Official | KARLIN, MARJI (CHIEF REVENUE OFFICER) |
| NPI Enumeration Date | 07/30/2006 |
Other providers sharing the same authorized official: KARLIN, MARJI
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 92,064 | $605K |
| 2019 | 258,431 | $8.68M |
| 2020 | 641,967 | $26.15M |
| 2021 | 941,825 | $36.42M |
| 2022 | 876,900 | $37.46M |
| 2023 | 585,418 | $25.53M |
| 2024 | 557,851 | $25.47M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 152,478 | 140,097 | $27.43M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 77,845 | 70,646 | $14.13M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 173,208 | 153,260 | $13.41M |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 91,611 | 82,044 | $8.64M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 32,018 | 30,297 | $6.21M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 82,662 | 71,600 | $4.67M |
| 36415 | Collection of venous blood by venipuncture | 303,637 | 155,850 | $4.14M |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 27,141 | 26,555 | $2.88M |
| S9083 | Global fee urgent care centers | 26,470 | 24,329 | $2.78M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 41,924 | 38,293 | $2.61M |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 15,068 | 14,760 | $2.36M |
| 70450 | Computed tomography, head or brain; without contrast material | 11,601 | 11,239 | $2.19M |
| 96361 | Intravenous infusion, hydration; each additional hour | 21,942 | 20,458 | $1.89M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9,954 | 9,659 | $1.72M |
| 90834 | Psychotherapy, 45 minutes with patient | 9,845 | 5,855 | $1.70M |
| G0378 | Hospital observation service, per hour | 1,272 | 1,240 | $1.50M |
| 81408 | 1,065 | 1,057 | $1.33M | |
| 99215 | Prolong outpt/office vis | 9,097 | 8,542 | $1.32M |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 70,922 | 62,611 | $1.25M |
| 99442 | 19,496 | 19,029 | $1.14M | |
| 81420 | Fetal chromosomal aneuploidy genomic sequence analysis panel | 1,502 | 1,488 | $1.01M |
| 90832 | Psychotherapy, 30 minutes with patient | 8,328 | 5,696 | $995K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 14,152 | 9,897 | $966K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 22,981 | 22,075 | $894K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 4,720 | 4,638 | $852K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 1,455 | 1,443 | $851K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 51,066 | 39,738 | $835K |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 1,842 | 1,828 | $813K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5,748 | 5,682 | $806K |
| D9999 | Unspecified adjunctive procedure, by report | 5,800 | 5,293 | $770K |
| D0999 | Unspecified diagnostic procedure, by report | 4,808 | 4,547 | $767K |
| 80048 | Basic metabolic panel (calcium, ionized) | 90,081 | 82,122 | $751K |
| 99205 | Prolong outpt/office vis | 3,865 | 3,764 | $750K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 27,817 | 27,187 | $725K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 5,907 | 5,867 | $683K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 11,793 | 11,161 | $675K |
| 76818 | 5,788 | 2,529 | $666K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 5,843 | 5,321 | $662K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 8,574 | 8,308 | $644K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 21,043 | 20,972 | $627K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 14,803 | 6,496 | $614K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 7,235 | 7,100 | $597K |
| 86480 | 11,614 | 11,435 | $589K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 11,304 | 8,607 | $582K |
| 76641 | 4,941 | 4,012 | $569K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 29,405 | 25,622 | $564K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 23,877 | 23,307 | $524K |
| 99441 | 12,335 | 11,970 | $516K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 44,491 | 44,335 | $510K |
| 52000 | 684 | 681 | $507K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 11,932 | 11,027 | $494K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 2,853 | 2,821 | $481K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 45,701 | 42,662 | $467K |
| 99443 | 6,310 | 5,995 | $465K | |
| 0002A | 14,572 | 14,526 | $454K | |
| 87536 | 4,702 | 4,604 | $438K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 3,005 | 2,988 | $437K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 22,826 | 20,506 | $434K |
| 76770 | 2,953 | 2,916 | $429K | |
| 99051 | 12,890 | 8,337 | $426K | |
| 0001A | 15,090 | 15,040 | $426K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 2,669 | 2,642 | $423K |
| 80053 | Comprehensive metabolic panel | 41,064 | 39,485 | $415K |
| 77066 | Tomosynthesis, mammo | 2,774 | 2,745 | $406K |
| H0049 | Alcohol and/or drug screening | 7,574 | 6,835 | $389K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 47,883 | 46,892 | $386K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 7,179 | 6,987 | $379K |
| 71046 | Radiologic examination, chest; 2 views | 26,237 | 25,458 | $378K |
| 80061 | Lipid panel | 38,577 | 37,927 | $375K |
| 72125 | Computed tomography, cervical spine; without contrast material | 3,825 | 3,725 | $369K |
| 86703 | 29,620 | 29,170 | $362K | |
| 90677 | 2,838 | 2,824 | $354K | |
| 85027 | 131,350 | 121,635 | $352K | |
| 70486 | 2,637 | 2,601 | $346K | |
| 12001 | 1,592 | 1,580 | $346K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 15,262 | 13,962 | $335K |
| 12011 | 1,615 | 1,602 | $333K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 2,476 | 1,279 | $331K |
| 90651 | 3,432 | 3,417 | $327K | |
| H0050 | Alcohol and/or drug services, brief intervention, per 15 minutes | 6,463 | 5,927 | $326K |
| H2011 | Crisis intervention service, per 15 minutes | 1,587 | 1,370 | $325K |
| 83036 | Hemoglobin; glycosylated (A1C) | 46,938 | 44,474 | $321K |
| J2357 | Injection, omalizumab, 5 mg | 386 | 227 | $313K |
| 80076 | 54,047 | 51,500 | $303K | |
| 86360 | 6,282 | 6,131 | $300K | |
| 90461 | 17,389 | 17,369 | $298K | |
| 90847 | Family psychotherapy with the patient present, 50 minutes | 1,135 | 762 | $294K |
| 71250 | 1,651 | 1,630 | $292K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 1,572 | 1,563 | $287K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 10,191 | 9,250 | $284K |
| 59025 | Fetal non-stress test | 2,795 | 1,856 | $281K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 12,612 | 12,552 | $279K |
| 99201 | 4,247 | 4,137 | $278K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2,364 | 2,341 | $276K |
| 86850 | 15,932 | 14,950 | $264K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 9,608 | 7,169 | $257K |
| 90715 | 11,318 | 11,160 | $247K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 1,446 | 1,427 | $244K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 3,461 | 3,320 | $240K |
| 90750 | 3,159 | 3,128 | $238K | |
| 90791 | Psychiatric diagnostic evaluation | 1,182 | 1,025 | $234K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 3,172 | 3,148 | $233K |
| 86359 | 6,275 | 6,124 | $231K | |
| 12002 | 1,077 | 1,055 | $229K | |
| 84443 | Thyroid stimulating hormone (TSH) | 22,926 | 22,305 | $227K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1,107 | 1,094 | $223K |
| 82948 | 50,889 | 41,426 | $220K | |
| 81161 | 1,101 | 1,092 | $209K | |
| 81329 | 1,690 | 1,654 | $202K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 7,800 | 3,508 | $189K |
| 96375 | Therapeutic injection; each additional sequential IV push | 17,436 | 13,998 | $188K |
| 99381 | 6,632 | 4,751 | $186K | |
| 77065 | Tomosynthesis, mammo | 1,670 | 1,592 | $184K |
| 90686 | 21,421 | 21,005 | $183K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 3,719 | 3,657 | $178K |
| 10060 | 1,184 | 1,131 | $175K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 8,751 | 8,638 | $174K |
| 76830 | Ultrasound, transvaginal | 3,706 | 3,586 | $171K |
| 86901 | 15,930 | 14,984 | $171K | |
| H0005 | Alcohol and/or drug services; group counseling by a clinician | 2,528 | 566 | $161K |
| 97802 | 7,072 | 6,714 | $158K | |
| 0004A | 4,330 | 4,325 | $158K | |
| 86780 | 18,381 | 17,703 | $156K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 7,888 | 7,845 | $156K |
| 81025 | 34,978 | 33,518 | $154K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 1,750 | 1,724 | $153K |
| 93970 | 702 | 694 | $151K | |
| J0517 | Injection, benralizumab, 1 mg | 270 | 260 | $150K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 3,476 | 3,332 | $142K |
| 90935 | Hemodialysis procedure with single evaluation by a physician | 866 | 75 | $140K |
| 59841 | 249 | 247 | $140K | |
| 97010 | 20,094 | 7,097 | $137K | |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | 3,363 | 3,203 | $137K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 362 | 359 | $136K |
| 29580 | 1,554 | 616 | $130K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 3,635 | 2,341 | $130K |
| J0561 | Injection, penicillin g benzathine, 100,000 units | 771 | 597 | $129K |
| J1756 | Injection, iron sucrose, 1 mg | 3,706 | 1,701 | $128K |
| D7210 | Extraction, erupted tooth requiring removal of bone and/or sectioning of tooth | 3,205 | 2,444 | $128K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 2,826 | 2,737 | $127K |
| 97161 | 1,362 | 1,361 | $124K | |
| T1013 | Sign language or oral interpretive services, per 15 minutes | 11,025 | 10,268 | $123K |
| 86900 | 15,891 | 14,947 | $121K | |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 119 | 114 | $116K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 166 | 166 | $111K |
| 76642 | 1,329 | 1,240 | $110K | |
| D0330 | Panoramic radiographic image | 5,929 | 5,684 | $110K |
| D0140 | Limited oral evaluation - problem focused | 9,348 | 8,553 | $110K |
| 73610 | 5,683 | 5,067 | $109K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 3,253 | 3,201 | $108K |
| 86803 | 11,562 | 11,369 | $108K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 3,898 | 3,822 | $106K |
| 57452 | 539 | 532 | $106K | |
| 73630 | 5,850 | 5,435 | $106K | |
| 87800 | 3,595 | 3,496 | $106K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 11,331 | 8,457 | $104K |
| 83655 | 9,674 | 9,586 | $104K | |
| 71045 | Radiologic examination, chest; single view | 14,411 | 13,809 | $100K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 1,409 | 1,363 | $97K |
| 96127 | 29,894 | 27,376 | $97K | |
| 11900 | 1,004 | 944 | $97K | |
| 88142 | 4,249 | 4,161 | $96K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 2,737 | 2,711 | $96K |
| 76536 | 972 | 965 | $93K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 504 | 493 | $92K |
| 77062 | 591 | 586 | $92K | |
| 97803 | 2,055 | 2,035 | $90K | |
| 73564 | 3,935 | 3,708 | $90K | |
| 90746 | 1,721 | 1,698 | $90K | |
| D7140 | Extraction, erupted tooth or exposed root | 3,732 | 2,968 | $90K |
| 81422 | 165 | 162 | $88K | |
| 72100 | 3,862 | 3,824 | $86K | |
| 86769 | 3,545 | 3,426 | $85K | |
| 76820 | 1,811 | 938 | $84K | |
| 76801 | 1,098 | 1,048 | $84K | |
| 97124 | 3,115 | 1,732 | $83K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 1,221 | 304 | $82K |
| 83880 | 5,668 | 5,415 | $80K | |
| 90732 | 878 | 845 | $79K | |
| J2426 | Injection, paliperidone palmitate extended release (invega sustenna), 1 mg | 150 | 144 | $78K |
| 73030 | 4,634 | 4,349 | $78K | |
| 74019 | 3,193 | 3,161 | $77K | |
| 81001 | 49,693 | 47,422 | $75K | |
| 73130 | 4,869 | 4,544 | $75K | |
| 93975 | 456 | 449 | $74K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 11,368 | 11,275 | $74K |
| 81243 | 1,630 | 1,596 | $73K | |
| 73110 | 4,003 | 3,522 | $73K | |
| 87340 | 10,193 | 9,954 | $72K | |
| 77336 | 324 | 82 | $72K | |
| 76825 | 277 | 261 | $71K | |
| 92250 | 1,821 | 1,734 | $70K | |
| 83970 | 2,599 | 2,532 | $70K | |
| 29125 | 636 | 605 | $69K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 1,418 | 1,416 | $69K |
| 99401 | 3,458 | 3,340 | $68K | |
| 87522 | Neg quan hep c or qual rna | 1,731 | 1,704 | $67K |
| D1110 | Prophylaxis - adult | 3,554 | 3,436 | $67K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 3,392 | 2,972 | $67K |
| 90697 | 3,116 | 3,113 | $66K | |
| H0001 | Alcohol and/or drug assessment | 395 | 356 | $66K |
| 92567 | 2,678 | 2,645 | $66K | |
| 93971 | 1,407 | 1,387 | $65K | |
| 92579 | 1,192 | 1,160 | $65K | |
| 86003 | 2,270 | 2,068 | $64K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 15,797 | 15,259 | $64K |
| 17110 | 392 | 380 | $63K | |
| 0072A | 1,499 | 1,497 | $63K | |
| 97167 | 577 | 576 | $62K | |
| 84153 | 4,409 | 4,294 | $61K | |
| 0071A | 1,589 | 1,589 | $61K | |
| J2315 | Injection, naltrexone, depot form, 1 mg | 72 | 71 | $59K |
| 20610 | 702 | 686 | $59K | |
| S9088 | Services provided in an urgent care center (list in addition to code for service) | 1,086 | 1,031 | $58K |
| 86762 | 4,829 | 4,667 | $58K | |
| 92557 | 1,782 | 1,528 | $58K | |
| 77049 | 153 | 151 | $56K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 268 | 267 | $56K |
| 86706 | 7,189 | 7,001 | $55K | |
| 83020 | 4,363 | 4,265 | $53K | |
| 73562 | 2,455 | 2,242 | $53K | |
| J0882 | Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis) | 275 | 87 | $52K |
| 84702 | 14,044 | 12,959 | $52K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 140 | 138 | $52K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 1,850 | 1,849 | $51K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 768 | 666 | $51K |
| 87535 | 1,490 | 1,482 | $51K | |
| 90670 | 4,913 | 4,900 | $50K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | 263 | 248 | $50K |
| 92133 | 1,381 | 1,373 | $48K | |
| 90734 | 1,534 | 1,527 | $48K | |
| 84439 | 6,221 | 6,078 | $44K | |
| D9430 | 2,844 | 2,501 | $44K | |
| 76870 | 714 | 703 | $42K | |
| 77412 | 193 | 24 | $41K | |
| 73590 | 3,094 | 2,907 | $41K | |
| 97162 | 419 | 418 | $41K | |
| 19083 | 62 | 56 | $41K | |
| 94375 | 891 | 703 | $40K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 81 | 81 | $40K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 2,535 | 2,494 | $39K |
| 90620 | 1,459 | 1,456 | $39K | |
| 76000 | 459 | 449 | $39K | |
| 82951 | 3,786 | 3,451 | $39K | |
| 96367 | 2,145 | 1,953 | $38K | |
| 76819 | Fetal biophysical profile; without non-stress testing | 495 | 466 | $38K |
| 94729 | 787 | 786 | $38K | |
| 0124A | 938 | 936 | $38K | |
| 74178 | 126 | 126 | $37K | |
| 99383 | 684 | 682 | $37K | |
| D0150 | Comprehensive oral evaluation - new or established patient | 3,170 | 2,886 | $36K |
| 99382 | 608 | 606 | $36K | |
| A9585 | Injection, gadobutrol, 0.1 ml | 1,284 | 1,258 | $36K |
| 83735 | 33,365 | 31,152 | $35K | |
| 92083 | 647 | 637 | $35K | |
| D0220 | Intraoral - periapical first radiographic image | 5,863 | 5,688 | $35K |
| 92015 | Determination of refractive state | 1,558 | 1,553 | $34K |
| 82728 | 4,010 | 3,920 | $34K | |
| 99384 | 801 | 794 | $33K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | 487 | 439 | $32K |
| 73502 | 1,655 | 1,546 | $31K | |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | 141 | 139 | $31K |
| 84484 | 24,837 | 22,819 | $30K | |
| 92582 | 332 | 319 | $30K | |
| 91320 | 680 | 680 | $30K | |
| 82105 | 2,451 | 2,414 | $30K | |
| 82043 | 7,114 | 6,970 | $29K | |
| 93325 | 1,217 | 1,141 | $29K | |
| 82607 | 3,388 | 3,308 | $29K | |
| 73090 | 2,292 | 2,058 | $29K | |
| 85610 | 13,467 | 12,624 | $29K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 476 | 451 | $28K |
| 82803 | 3,821 | 3,667 | $28K | |
| 77080 | 1,092 | 1,078 | $27K | |
| 41899 | Unlisted procedure, dentoalveolar structures | 61 | 61 | $27K |
| 82785 | 1,933 | 1,893 | $27K | |
| 81002 | 8,362 | 6,551 | $27K | |
| 94726 | 469 | 469 | $27K | |
| 73565 | 779 | 741 | $26K | |
| 93923 | 252 | 243 | $26K | |
| 86765 | 2,523 | 2,464 | $26K | |
| 87486 | 1,789 | 1,764 | $26K | |
| 81405 | 149 | 147 | $25K | |
| 77061 | 189 | 189 | $25K | |
| 90739 | 264 | 262 | $24K | |
| 80320 | 9,637 | 8,846 | $24K | |
| 73700 | 124 | 119 | $24K | |
| 87081 | 5,845 | 5,800 | $24K | |
| 90656 | 2,117 | 2,116 | $24K | |
| 70491 | 118 | 118 | $23K | |
| 86787 | 2,526 | 2,463 | $23K | |
| D0120 | Periodic oral evaluation - established patient | 2,637 | 2,498 | $23K |
| 84402 | 970 | 942 | $23K | |
| 85730 | 11,212 | 10,928 | $23K | |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 717 | 530 | $23K |
| 86735 | 2,412 | 2,366 | $22K | |
| 73080 | 1,562 | 1,429 | $22K | |
| 96161 | 4,587 | 4,441 | $22K | |
| 90480 | 761 | 761 | $22K | |
| 76821 | 253 | 205 | $22K | |
| D0274 | Bitewings - four radiographic images | 2,399 | 2,353 | $21K |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 1,601 | 1,505 | $21K |
| 84100 | 24,740 | 23,336 | $21K | |
| 70498 | 115 | 115 | $21K | |
| 82677 | 1,073 | 1,051 | $21K | |
| 87517 | 498 | 476 | $21K | |
| 88104 | 430 | 423 | $21K | |
| 87631 | 642 | 640 | $21K | |
| 87581 | 1,790 | 1,765 | $21K | |
| 90698 | 4,140 | 4,132 | $21K | |
| 90707 | 1,556 | 1,551 | $20K | |
| 88108 | 446 | 437 | $20K | |
| 51798 | 130 | 130 | $20K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 26,812 | 25,069 | $19K |
| 90674 | 972 | 968 | $19K | |
| 81361 | 190 | 187 | $19K | |
| 95819 | 44 | 44 | $19K | |
| 90633 | 3,038 | 3,036 | $19K | |
| 73120 | 864 | 819 | $19K | |
| 83001 | 1,048 | 1,010 | $19K | |
| 82274 | 1,941 | 1,930 | $19K | |
| 76827 | 277 | 261 | $19K | |
| 73600 | 1,022 | 969 | $18K | |
| 83550 | 3,629 | 3,554 | $18K | |
| 58300 | 165 | 159 | $18K | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 6,711 | 6,562 | $18K |
| S0190 | Mifepristone, oral, 200 mg | 286 | 286 | $18K |
| 84146 | 984 | 947 | $18K | |
| 0003A | 451 | 451 | $18K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1,384 | 1,368 | $18K |
| 90846 | Family psychotherapy without the patient present, 50 minutes | 128 | 109 | $18K |
| D1120 | Prophylaxis - child | 2,169 | 2,153 | $17K |
| 86704 | 1,930 | 1,883 | $17K | |
| 95117 | 1,397 | 974 | $17K | |
| 83690 | 21,439 | 20,498 | $16K | |
| 83525 | 1,444 | 1,425 | $16K | |
| 73140 | 1,112 | 1,089 | $16K | |
| J2704 | Injection, propofol, 10 mg | 6,292 | 6,162 | $15K |
| 90716 | 1,519 | 1,518 | $15K | |
| 11982 | 53 | 43 | $15K | |
| 97164 | 238 | 236 | $15K | |
| 94060 | 424 | 397 | $15K | |
| 83540 | 3,809 | 3,723 | $15K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 40 | 39 | $15K |
| 87186 | 3,522 | 3,276 | $15K | |
| 74018 | 836 | 829 | $15K | |
| 90681 | 2,866 | 2,860 | $15K | |
| 84403 | 598 | 569 | $15K | |
| 73552 | 1,114 | 1,065 | $15K | |
| 88304 | 542 | 537 | $14K | |
| 81401 | 182 | 179 | $14K | |
| 96910 | 111 | 25 | $14K | |
| 83002 | 781 | 747 | $14K | |
| 73560 | 539 | 496 | $14K | |
| 73070 | 1,024 | 928 | $13K | |
| 96417 | 212 | 139 | $13K | |
| 73620 | 745 | 694 | $13K | |
| 84704 | 1,072 | 1,050 | $13K | |
| 82550 | 12,727 | 12,245 | $13K | |
| 90744 | 2,424 | 2,420 | $13K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 24,930 | 23,621 | $13K |
| 72040 | 563 | 561 | $12K | |
| 73060 | 1,039 | 959 | $12K | |
| 81257 | 205 | 203 | $12K | |
| 73100 | 546 | 471 | $12K | |
| 82570 | 4,734 | 4,549 | $12K | |
| 51741 | 65 | 65 | $12K | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 2,698 | 2,559 | $12K |
| 90733 | 103 | 103 | $12K | |
| 97014 | 841 | 490 | $12K | |
| 92550 | 373 | 346 | $11K | |
| 86336 | 1,072 | 1,050 | $11K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 8,385 | 6,997 | $11K |
| 83605 | 10,378 | 9,904 | $11K | |
| 84154 | 711 | 676 | $11K | |
| 76857 | 297 | 297 | $11K | |
| 58301 | 64 | 55 | $11K | |
| 72070 | 447 | 425 | $11K | |
| 92650 | 341 | 337 | $11K | |
| 82805 | 1,641 | 1,603 | $11K | |
| 0081A | 246 | 246 | $11K | |
| 12013 | 36 | 36 | $10K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 8,610 | 7,748 | $10K |
| 82746 | 1,106 | 1,073 | $10K | |
| 88300 | 761 | 738 | $10K | |
| D0230 | Intraoral - periapical each additional radiographic image | 2,755 | 2,745 | $10K |
| 82533 | 564 | 469 | $10K | |
| D9310 | 328 | 311 | $9K | |
| 93226 | 182 | 182 | $9K | |
| 71271 | 51 | 51 | $9K | |
| 11104 | 59 | 52 | $9K | |
| 70496 | 84 | 84 | $9K | |
| 99385 | 145 | 144 | $9K | |
| J2356 | Injection, tezepelumab-ekko, 1 mg | 13 | 12 | $9K |
| 51702 | 100 | 91 | $9K | |
| 81381 | 69 | 68 | $9K | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 4,701 | 4,290 | $9K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 85 | 80 | $9K |
| D1206 | Topical application of fluoride varnish | 2,152 | 2,133 | $9K |
| 96523 | 237 | 87 | $9K | |
| 86038 | 1,101 | 1,054 | $8K | |
| 82248 | 2,452 | 2,155 | $8K | |
| 84550 | 3,160 | 3,014 | $8K | |
| 86592 | 2,574 | 2,288 | $8K | |
| J1953 | Injection, levetiracetam, 10 mg | 1,503 | 1,320 | $8K |
| 99493 | 144 | 143 | $8K | |
| 72050 | 286 | 286 | $8K | |
| J0690 | Injection, cefazolin sodium, 500 mg | 2,566 | 2,507 | $8K |
| 84156 | 3,018 | 2,859 | $8K | |
| 71101 | 563 | 550 | $8K | |
| 0082A | 174 | 174 | $8K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 37 | 36 | $8K |
| 83516 | 732 | 699 | $8K | |
| 87338 | 799 | 797 | $8K | |
| J1631 | Injection, haloperidol decanoate, per 50 mg | 736 | 692 | $8K |
| 83615 | 2,370 | 2,209 | $7K | |
| 97139 | 453 | 312 | $7K | |
| 95930 | 3,147 | 3,146 | $7K | |
| 81003 | 3,612 | 3,501 | $7K | |
| 87521 | Neg quan hep c or qual rna | 277 | 270 | $7K |
| D0210 | Intraoral - complete series of radiographic images | 825 | 813 | $7K |
| 93225 | 125 | 125 | $7K | |
| 90710 | 917 | 917 | $7K | |
| 72170 | 887 | 873 | $7K | |
| H0002 | Behavioral health screening to determine eligibility for admission to treatment program | 34 | 34 | $7K |
| 82670 | 242 | 234 | $7K | |
| 57460 | 14 | 14 | $7K | |
| 81400 | 183 | 180 | $7K | |
| 10120 | 37 | 37 | $6K | |
| 93320 | 139 | 138 | $6K | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 2,044 | 1,266 | $6K |
| H0038 | Self-help/peer services, per 15 minutes | 241 | 232 | $6K |
| 81255 | 183 | 180 | $6K | |
| 85045 | 2,195 | 1,996 | $6K | |
| 96156 | 69 | 61 | $6K | |
| 82977 | 928 | 882 | $6K | |
| 81251 | 182 | 179 | $6K | |
| 81200 | 181 | 178 | $6K | |
| H2010 | Comprehensive medication services, per 15 minutes | 78 | 71 | $6K |
| 92555 | 156 | 153 | $5K | |
| 99407 | 211 | 193 | $5K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 1,345 | 994 | $5K |
| 96402 | 176 | 170 | $5K | |
| 86376 | 379 | 368 | $5K | |
| 97032 | 354 | 210 | $5K | |
| 88141 | 272 | 271 | $5K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 12 | 12 | $5K |
| 86140 | 2,236 | 2,182 | $5K | |
| 81260 | 185 | 182 | $5K | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 13,937 | 12,320 | $5K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 1,637 | 1,597 | $5K |
| 82247 | 1,211 | 957 | $5K | |
| 86696 | 401 | 378 | $5K | |
| Q3014 | Telehealth originating site facility fee | 1,189 | 1,008 | $5K |
| 72131 | 28 | 28 | $5K | |
| G0109 | Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes | 270 | 253 | $5K |
| 90653 | 277 | 277 | $5K | |
| J1644 | Injection, heparin sodium, per 1000 units | 3,712 | 488 | $5K |
| 90662 | 366 | 366 | $4K | |
| 97168 | 75 | 74 | $4K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 7,796 | 6,951 | $4K |
| 97035 | 306 | 145 | $4K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 5,523 | 5,313 | $4K |
| 85007 | 2,861 | 2,758 | $4K | |
| 90696 | 756 | 756 | $4K | |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | 156 | 131 | $4K |
| 97116 | 154 | 102 | $4K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 14 | 14 | $4K |
| 82947 | 1,063 | 1,042 | $4K | |
| 86593 | 1,411 | 1,387 | $4K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 4,829 | 4,723 | $4K |
| 85651 | 1,677 | 1,627 | $4K | |
| 99412 | 129 | 129 | $4K | |
| 59425 | 76 | 61 | $4K | |
| 11981 | 27 | 26 | $4K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 96 | 52 | $4K |
| 51726 | 15 | 15 | $4K | |
| 73521 | 173 | 171 | $4K | |
| 82310 | 1,017 | 551 | $4K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 307 | 301 | $4K |
| J1170 | Injection, hydromorphone, up to 4 mg | 2,341 | 1,864 | $4K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 779 | 768 | $4K |
| 92551 | 5,045 | 5,038 | $4K | |
| 87400 | 148 | 147 | $4K | |
| 69200 | 42 | 40 | $3K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 808 | 721 | $3K |
| 82397 | 1,843 | 1,808 | $3K | |
| 96368 | 547 | 537 | $3K | |
| 92227 | 198 | 198 | $3K | |
| 0074A | 74 | 74 | $3K | |
| 93308 | 32 | 32 | $3K | |
| 87070 | 908 | 877 | $3K | |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 13 | 13 | $3K |
| 93017 | 55 | 54 | $3K | |
| 86695 | 337 | 315 | $3K | |
| 80165 | 575 | 539 | $3K | |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | 4,103 | 3,858 | $3K |
| 82952 | 380 | 369 | $3K | |
| 84703 | 922 | 909 | $3K | |
| 85018 | 2,561 | 1,415 | $3K | |
| 94760 | 1,752 | 1,738 | $3K | |
| 87040 | 1,356 | 1,309 | $3K | |
| 92202 | 115 | 114 | $3K | |
| 85379 | 2,026 | 1,995 | $3K | |
| 29130 | 28 | 26 | $3K | |
| T2022 | Case management, per month | 238 | 230 | $3K |
| J7510 | Prednisolone oral, per 5 mg | 2,935 | 2,891 | $3K |
| 20550 | 25 | 25 | $2K | |
| 76942 | 18 | 18 | $2K | |
| 0154A | 70 | 70 | $2K | |
| 82010 | 2,346 | 2,201 | $2K | |
| 99386 | 25 | 24 | $2K | |
| 96160 | 199 | 185 | $2K | |
| 72190 | 127 | 125 | $2K | |
| 76377 | 13 | 13 | $2K | |
| H0004 | Behavioral health counseling and therapy, per 15 minutes | 39 | 27 | $2K |
| 70360 | 85 | 85 | $2K | |
| 0012A | 105 | 105 | $2K | |
| J7050 | Infusion, normal saline solution, 250 cc | 2,721 | 2,059 | $2K |
| 90694 | 193 | 193 | $2K | |
| 84481 | 161 | 156 | $2K | |
| 90714 | 179 | 178 | $2K | |
| 92002 | 37 | 35 | $2K | |
| 99242 | 26 | 26 | $2K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 4,356 | 3,972 | $2K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 11,872 | 11,279 | $2K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 4,935 | 4,743 | $2K |
| 96380 | 232 | 232 | $2K | |
| J8540 | Dexamethasone, oral, 0.25 mg | 448 | 391 | $2K |
| 99173 | 5,509 | 5,503 | $2K | |
| 90678 | 29 | 29 | $2K | |
| 90849 | 21 | 13 | $2K | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 851 | 845 | $2K |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | 382 | 378 | $2K |
| G0390 | Trauma response team associated with hospital critical care service | 112 | 111 | $2K |
| 99152 | 259 | 258 | $1K | |
| 85060 | 90 | 86 | $1K | |
| 92552 | 37 | 36 | $1K | |
| 88342 | 25 | 25 | $1K | |
| 84132 | 510 | 479 | $1K | |
| 93247 | 12 | 12 | $1K | |
| 76813 | 14 | 13 | $1K | |
| 17250 | 15 | 15 | $1K | |
| 0011A | 112 | 106 | $1K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5,584 | 5,506 | $1K |
| 86708 | 152 | 142 | $1K | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 732 | 724 | $1K |
| 0083A | 31 | 31 | $1K | |
| 99397 | 68 | 68 | $1K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 754 | 710 | $1K |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | 30 | 29 | $1K |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 8,447 | 7,297 | $1K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 3,310 | 2,709 | $1K |
| 86255 | 64 | 56 | $1K | |
| D1351 | Sealant - per tooth | 271 | 102 | $1K |
| 15853 | 20 | 19 | $1K | |
| 80069 | 177 | 168 | $1K | |
| D1330 | 3,386 | 3,273 | $1K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 3,774 | 3,648 | $1K |
| 86580 | 360 | 357 | $1K | |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 11,421 | 10,176 | $1K |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 387 | 380 | $1K |
| 87420 | 462 | 451 | $1K | |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | 125 | 101 | $1K |
| 0502F | 246 | 176 | $1K | |
| 92134 | 25 | 25 | $1K | |
| 94727 | 30 | 30 | $1K | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 1,646 | 1,479 | $997.24 |
| D0272 | Bitewings - two radiographic images | 506 | 506 | $957.87 |
| J1790 | Injection, droperidol, up to 5 mg | 1,941 | 1,806 | $935.13 |
| 87109 | 92 | 92 | $916.20 | |
| 90685 | 346 | 346 | $897.92 | |
| 76775 | 55 | 53 | $893.45 | |
| T1023 | Screening to determine the appropriateness of consideration of an individual for participation in a specified program, project or treatment protocol, per encounter | 15 | 12 | $885.87 |
| 76881 | 12 | 12 | $884.41 | |
| 86008 | 15 | 12 | $880.99 | |
| 82652 | 26 | 26 | $872.80 | |
| 20552 | 28 | 28 | $871.15 | |
| 83883 | 61 | 53 | $861.01 | |
| J1815 | Injection, insulin, per 5 units | 1,446 | 1,076 | $820.89 |
| 87075 | 258 | 252 | $814.45 | |
| 96376 | 893 | 837 | $813.44 | |
| 93246 | 12 | 12 | $789.97 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 181 | 179 | $773.30 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 3,311 | 2,548 | $760.39 |
| D8660 | 45 | 45 | $739.50 | |
| D9222 | 36 | 36 | $735.94 | |
| 82378 | 53 | 51 | $732.89 | |
| D9230 | Inhalation of nitrous oxide / analgesia, anxiolysis | 143 | 139 | $720.00 |
| 83010 | 69 | 68 | $718.23 | |
| 95251 | 16 | 16 | $684.64 | |
| 84445 | 13 | 13 | $673.67 | |
| 86430 | 142 | 133 | $661.98 | |
| 11721 | 37 | 37 | $644.69 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 411 | 408 | $621.20 |
| 84112 | 43 | 38 | $566.22 | |
| D5899 | 46 | 37 | $554.91 | |
| 86880 | 63 | 59 | $553.43 | |
| 84520 | 319 | 195 | $540.42 | |
| S0191 | Misoprostol, oral, 200 mcg | 396 | 385 | $523.81 |
| 86160 | 48 | 37 | $513.96 | |
| J1630 | Injection, haloperidol, up to 5 mg | 2,636 | 2,293 | $506.00 |
| 73200 | 12 | 12 | $498.67 | |
| 82465 | 114 | 110 | $496.38 | |
| 73660 | 41 | 40 | $478.58 | |
| 74022 | 25 | 25 | $475.28 | |
| Q0166 | Granisetron hydrochloride, 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen | 224 | 133 | $471.34 |
| 87529 | 16 | 12 | $464.13 | |
| J2060 | Injection, lorazepam, 2 mg | 3,472 | 3,025 | $454.11 |
| D4341 | 38 | 24 | $446.46 | |
| 92588 | 13 | 13 | $444.04 | |
| 90682 | 93 | 93 | $440.30 | |
| 86235 | 16 | 12 | $436.46 | |
| 86705 | 78 | 78 | $428.67 | |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | 376 | 365 | $420.91 |
| 87593 | 12 | 12 | $413.37 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 58 | 58 | $402.56 |
| J3411 | Injection, thiamine hcl, 100 mg | 442 | 402 | $376.88 |
| 82955 | 30 | 28 | $355.79 | |
| 88143 | 13 | 13 | $344.98 | |
| D0603 | 204 | 196 | $340.76 | |
| 82784 | 29 | 24 | $338.86 | |
| 87205 | 350 | 334 | $331.39 | |
| 90611 | 311 | 310 | $331.20 | |
| 98960 | 15 | 14 | $327.58 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 316 | 314 | $319.57 |
| 86800 | 25 | 24 | $308.74 | |
| D4355 | 603 | 601 | $280.79 | |
| 86225 | 37 | 36 | $279.54 | |
| 73000 | 15 | 14 | $267.53 | |
| 86334 | 15 | 12 | $262.19 | |
| 86709 | 32 | 31 | $260.87 | |
| 90756 | 12 | 12 | $258.72 | |
| 71047 | 14 | 14 | $258.18 | |
| 82172 | 14 | 13 | $250.43 | |
| 88720 | 553 | 461 | $245.00 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 401 | 361 | $243.68 |
| 84165 | 38 | 38 | $225.79 | |
| 86777 | 14 | 14 | $209.60 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 16 | 16 | $200.46 |
| 76514 | 12 | 12 | $199.27 | |
| J2310 | Injection, naloxone hydrochloride, per 1 mg | 27 | 26 | $181.05 |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 18 | 18 | $176.10 |
| 86141 | 78 | 76 | $166.96 | |
| 88280 | 13 | 13 | $166.15 | |
| 83021 | 268 | 268 | $145.98 | |
| 82150 | 94 | 92 | $143.45 | |
| D1208 | Topical application of fluoride, excluding varnish | 242 | 241 | $135.95 |
| 90381 | 39 | 37 | $101.25 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 140 | 127 | $97.09 |
| G0008 | Administration of influenza virus vaccine | 540 | 539 | $96.92 |
| 80178 | 26 | 25 | $90.65 | |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | 138 | 136 | $90.59 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 12 | 12 | $86.79 |
| 84155 | 39 | 39 | $86.73 | |
| D0350 | 13 | 13 | $80.30 | |
| 90688 | 12 | 12 | $76.71 | |
| 36416 | 110 | 107 | $70.70 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 21 | 21 | $56.93 |
| 90713 | 12 | 12 | $54.97 | |
| 3078F | 65,328 | 50,476 | $53.12 | |
| 90380 | 13 | 13 | $50.70 | |
| J3480 | Injection, potassium chloride, per 2 meq | 109 | 96 | $50.45 |
| 82553 | 38 | 38 | $46.71 | |
| 81015 | 19 | 18 | $46.34 | |
| J0456 | Injection, azithromycin, 500 mg | 53 | 44 | $33.19 |
| 3074F | 66,529 | 51,571 | $27.71 | |
| 3079F | 26,369 | 22,682 | $25.00 | |
| 3075F | 17,801 | 15,783 | $25.00 | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 51 | 51 | $22.71 |
| 86701 | 59 | 59 | $20.00 | |
| 82540 | 356 | 356 | $19.44 | |
| 87077 | 116 | 116 | $17.46 | |
| 85660 | 12 | 12 | $16.49 | |
| 85384 | 12 | 12 | $12.24 | |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | 13 | 13 | $10.01 |
| J3360 | Injection, diazepam, up to 5 mg | 12 | 12 | $6.29 |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | 32 | 31 | $5.34 |
| J0736 | Injection, clindamycin phosphate, 300 mg | 25 | 25 | $4.40 |
| 1159F | 7,022 | 4,415 | $0.82 | |
| 1160F | 5,268 | 3,876 | $0.82 | |
| 3077F | 13,095 | 10,782 | $0.66 | |
| 3080F | 5,238 | 4,702 | $0.25 | |
| D0601 | 36 | 36 | $0.00 | |
| 3044F | 320 | 319 | $0.00 | |
| 80050 | General health panel | 284 | 284 | $0.00 |
| 4293F | 953 | 743 | $0.00 | |
| 99429 | 131 | 118 | $0.00 | |
| 71020 | 105 | 105 | $0.00 | |
| D1310 | 190 | 190 | $0.00 | |
| 87301 | 13 | 13 | $0.00 | |
| 1220F | 1,670 | 1,445 | $0.00 | |
| 99406 | 739 | 737 | $0.00 | |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 14 | 14 | $0.00 |
| 44388 | 14 | 14 | $0.00 | |
| 90474 | 25 | 25 | $0.00 | |
| 1126F | 17 | 17 | $0.00 | |
| 1170F | 38 | 38 | $0.00 | |
| 99499 | 7,874 | 5,842 | $0.00 | |
| 99408 | 828 | 742 | $0.00 | |
| D0190 | 604 | 604 | $0.00 | |
| 99080 | 5,883 | 1,223 | $0.00 | |
| 86431 | 12 | 12 | $0.00 | |
| 48510 | 36 | 36 | $0.00 | |
| 71010 | 28 | 26 | $0.00 | |
| G8984 | Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals | 14 | 14 | $0.00 |
| G8985 | Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 14 | 14 | $0.00 |
| 2022F | 13 | 13 | $0.00 | |
| 3725F | 18 | 15 | $0.00 |